Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (81-90 of 270) with videos related to

Pageof 27
Sort By:
Molecular Cancer Therapeutics|August 23, 2013
Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivoChristian Thomas, Francois Lamoureux, Claire Crafter, et al.
International Journal of Cancer|April 9, 2013
TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signalingNaokazu Ibuki, Mazyar Ghaffari, Mitali Pandey, et al.
Molecular Therapy. Nucleic Acids|November 25, 2019
Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor GeneJindan Luo, Yinan Li, Wei Zheng, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2009
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacyAlain G Musende, Andy Eberding, Catherine Wood, et al.
International Journal of Cancer|July 23, 2011
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progressionLatif A Wafa, Helen Cheng, Nathan Plaa, et al.
Medicines (Basel, Switzerland)|July 2, 2021
Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate CancerMohamed Ben-Eltriki, Subrata Deb, Gehana Shankar, et al.
Molecular Cancer Therapeutics|June 8, 2012
Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancerMasafumi Kumano, Junya Furukawa, Masaki Shiota, et al.
Cancer Letters|July 5, 2025
Endoplasmic reticulum stress-driven nucleotide catabolism fuels prostate cancerKe Deng, Nora Pällmann, Marte Livgård, et al.
Nucleic Acids Research|December 23, 2021
Regulation of AR mRNA translation in response to acute AR pathway inhibitionSyam Prakash Somasekharan, Neetu Saxena, Fan Zhang, et al.
European Urology|August 31, 2017
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)Hendrik Borgmann, Nada Lallous, Deniz Ozistanbullu, et al.
Pageof 27

Showing results (81-90 of 270) with videos related to

Sort By:
Pageof 27
Molecular Cancer Therapeutics|August 23, 2013
Synergistic targeting of PI3K/AKT pathway and androgen receptor axis significantly delays castration-resistant prostate cancer progression in vivoChristian Thomas, Francois Lamoureux, Claire Crafter, et al.
International Journal of Cancer|April 9, 2013
TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signalingNaokazu Ibuki, Mazyar Ghaffari, Mitali Pandey, et al.
Molecular Therapy. Nucleic Acids|November 25, 2019
Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor GeneJindan Luo, Yinan Li, Wei Zheng, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2009
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacyAlain G Musende, Andy Eberding, Catherine Wood, et al.
International Journal of Cancer|July 23, 2011
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progressionLatif A Wafa, Helen Cheng, Nathan Plaa, et al.
Medicines (Basel, Switzerland)|July 2, 2021
Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate CancerMohamed Ben-Eltriki, Subrata Deb, Gehana Shankar, et al.
Molecular Cancer Therapeutics|June 8, 2012
Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancerMasafumi Kumano, Junya Furukawa, Masaki Shiota, et al.
Cancer Letters|July 5, 2025
Endoplasmic reticulum stress-driven nucleotide catabolism fuels prostate cancerKe Deng, Nora Pällmann, Marte Livgård, et al.
Nucleic Acids Research|December 23, 2021
Regulation of AR mRNA translation in response to acute AR pathway inhibitionSyam Prakash Somasekharan, Neetu Saxena, Fan Zhang, et al.
European Urology|August 31, 2017
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)Hendrik Borgmann, Nada Lallous, Deniz Ozistanbullu, et al.
Pageof 27